Quick Takeaways
- Ron Bentsur has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $27,752,858.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Ron Bentsur
- Location
- New York, NY
- Summary
- The estimated net worth of Ron Bentsur is at least $27,752,858 dollars as of 09 Jan 2026. Ron Bentsur is the Chairman & CEO, Director, 10%+ Owner of Nuvectis Pharma, Inc. and owns shares of Nuvectis Pharma, Inc. (NVCT) stock worth about $27.75M.
- Signature
- /s/ Ron Bentsur
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Ron Bentsur and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: Nuvectis Pharma, Inc. ($27,752,858).
- Past-year value change for that position: +$28,600.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Ron Bentsur
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| NVCT | Nuvectis Pharma, Inc. | Chairman & CEO, Director, 10%+ Owner | $27,752,858 | +$28,600 | +0.1% | 06 Jan 2026 |
| XAIR | Beyond Air, Inc. | Director | 22 Nov 2024 |
Insider Transactions Reported by Ron Bentsur:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.